期刊文献+

真核表达hCAP-18/LL-37成熟肽对树突状细胞表面分子表达的影响 被引量:1

Effects of eukaryotic expressive mature peptide of hCAP-18/LL-37 on expressions of membrane molecules on dendritic cells
下载PDF
导出
摘要 目的:研究真核表达的人源阳离子抗菌肽-18(hCAP-18)成熟肽LL-37对树突状细胞(DCs)表面分子表达的影响。方法:通过基因克隆方法构建hCAP-18成熟肽LL-37真核表达载体pcDNA4/Myc-His-LL-37,转染人胚肾HEK293细胞株,转染48 h后收获培养上清,与体外以rh-GM-CSF、rh-IL-4联合培养定向诱导分化的不成熟DCs共培养48 h,收获DCs;流式细胞仪检测DCs表面分子CD40及HLA-DR的表达。结果:成功构建成熟肽真核表达载体pcDNA4/Myc-His-LL-37,并实现在其真核细胞HEK293中的表达;流式细胞仪结果显示,pcDNA4/Myc-His-LL-37基因转染HEK293细胞培养上清刺激组DCs中CD40及HLA-DR的表达阳性率与对照组比较均明显升高(P<0.05)。结论:构建了真核表达的hCAP-18成熟肽LL-37,其可上调DCs表面分子CD40及HLA-DR的表达,促进DCs功能的成熟。 Objective To study the effects of eukaryotic expressive mature peptide LL-37 of human cationic antimicrobial peptide (hCAP-18) on the expressions of membrane molecules on dendritic cells (DCs) . Methods By gene cloning, the eukaryotic expressive plasmid pcDNA4/Myc-His-LL-37 for the mature peptide LL-37 of hCAP-18 was constructed. Then they were transfected into HEK293 cell lines. After the cell lines were cultivated for 48 h, the supernatant was collected. Then the DCs from peripheral blood mononuclear cells (PBMCs) induced by rh-GM- CSF and rh IL-4 were cultivated with the supernatant for 48h. The expressions of membrane molecules CD40 and HLA-DR on DCs were detected by flow cytometry (FCM). Results The eukaryotic expressive plasmid pcDNA4/ Myc-His LL-37 was constructed successfully and it expressed in eukaryotic cells HEK293. FCM results indicated that the expressions of CD40 and HI.A-DR on the membrane of DCs which were stimulated by the supernatant produced by pcDNA4/Myc His-LL-37 were higher than those in control group (P〈 0.05) . Conclusion The mature peptide 1.L-37 of hCAP-18 is constructed successfully and it can increase the expressions of the membrane molecules on DCs such as CD40 and HLA DR.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2009年第3期482-486,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科技发展计划项目资助课题(200705357)
关键词 hCAP-18/LL-37 成熟肽 树突状细胞 表面分子 hCAP-18/LL-37 mature peptide dendritic cells membrane molecules
  • 相关文献

参考文献8

  • 1Kai-Larsen Y, Agerberth B. The role of the multifunctional peptide LL-37 in host defense [J]. Front Biosci, 2008, 13 (10): 3760-3767.
  • 2Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications [J]. Curr Opin Hematol, 2009, 16 (1): 41-47.
  • 3Niyonsaba F, Ushio H, Nakano N, et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines [J]. J Invest Dermatol, 2007, 127 (3): 594-604.
  • 4Carretero M, Escamez MJ, Garcia M, et al. In vitro and in vivo wound healing promoting activities of human cathelicidin LL-37 [J]. J Invest Dermatol, 2008, 128 (1): 223-236.
  • 5Malmsten M, Davoudi M, Walse B, et al. Antimicrobial peptides derived from growth factors [J]. Growth Factors, 2007, 25 (1): 60-70.
  • 6Bandholtz L, Ekman GJ, Vilhelmsson M, et al. Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype[J]. Scand J Immunol, 2006, 63 (6): 410-419.
  • 7Starner TD, Agerberth B, Gudmundsson GH, et al. Expression and activity of beta-defensins and LL-37 in the developing human lung [J]. J Immunol, 2005, 174 (3): 1608-1615
  • 8Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelieidin family of antimierobial peptides [J]. Biochim Biophys Acta, 2006, 1758 (9): 1408-1425.

同被引文献11

  • 1Barlow PG, Li Y, Wilkinson TS, et al. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system [J]. J Leukoc Biol, 2006, 80 (3): 509-520.
  • 2Howell MD, Wollenberg A, Gallo RL, et al. Cathelicidin deficiency predisposes to eczema herpeticum [J]. J Allergy Clin Immunol, 2006, 117 (4) : 836-841.
  • 3Heilbom JD, Nilsson MF, Kratz G, et al. The eathelieidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium [J]. J Invest Dermatol, 2003, 120 (3): 379-389.
  • 4Akashi-Takamura S, Miyake K. Toll-like receptors(TLRs) and immune disorders [J]. J Infect Chemother, 2006, 12 (5): 233-240.
  • 5Koczulla R, Von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J]. J Clin Invest, 2003, 111 (11): 1665-1672.
  • 6Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a laetoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties [J]. Cell Mol Life Sci, 2005, 62 (22): 2588-2598.
  • 7Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases [J]. Inflammopharmacology, 2007, 15 (6): 252-259.
  • 8Rivas-Santiago B, Hemandez-Pando R, Carranza C, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells [J]. Infect Immun, 2008, 76 (3): 935-941.
  • 9Elssner A, Duncan M, Gavrilin M, et al. A novel P2X7 receptor activator, the human eathelicidin-derived peptide LL37, induces IL-1 beta processing and release [J]. J Immunol, 2004, 172 ( 8 ) : 4987-4994.
  • 10Yu J, Mookherjee N, Wee K, et al. Host defense peptide LL- 37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways [J]. J Immunol, 2007, 179 ( 11 ) : 7684-7691.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部